BioStrand (a subsidiary of IPA)’s Post

We're celebrating another win! As BioStrand, we also won the Best Demo award for the most creative use of AI technology at the InterSystems Global Summit in June! We proudly took home the prestigious Impact Award as well. Thank you to InterSystems for an invitation to the event. LENSᵃⁱ™ Integrated Intelligence Technology Vector Search capabilities, with InterSystems inside, recently launched. LENSᵃⁱ’s #foundationalAImodel powered by HYFT® technology is transforming drug discovery by leveraging #vectorsearch to map complex relationships between data points. This innovative approach identifies similarities and patterns across vast biological datasets, uncovering potential drug candidates faster and more efficiently. By uniting text, sequence, structure, and function into a single platform, LENSᵃⁱ streamlines the #drugdiscovery and development process, making data useful in unprecedented ways.

  • No alternative text description for this image
Unai Arregui Maestre

Curious Learner / Part-Time Investor / AI enthusiast and researcher

4mo

Congrats to the whole team. First of many to come. Looking forward to see more demos and case studies

Kristin Taylor

Chief Financial Officer at IPA (ImmunoPrecise Antibodies)

4mo

BioStrand (a subsidiary of IPA) Dirk Van Hyfte Ingrid Brands Arnout Van Hyfte Jennifer Bath, Ph.D. Great recognition of the hard work on bringing LENSai to the market and the great progress!

Aditya Badola

Msc Bioinformatics | Perseus Biomics

4mo

Wow! Congratulations on the win 🍻

See more comments

To view or add a comment, sign in

Explore topics